Crossmark

Sex differences in serious adverse drug reactions in patients receiving immunotherapy, targeted therapy, or chemotherapy: a disproportionality analysis of the VigiBase®

Crossref DOI link: https://doi.org/10.1007/s00228-022-03332-z

Published Online: 2022-05-13

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wabont, Guillaume https://orcid.org/0000-0002-2594-0993
Bergeron, Sandrine https://orcid.org/0000-0002-4693-9043
Gautier, Sophie

Barus, Romain https://orcid.org/0000-0002-1512-1265
License Information

Text and Data Mining valid from 2022-05-13

Version of Record valid from 2022-05-13
More Information

Article History

Received: 24 March 2022

Accepted: 6 May 2022

First Online: 13 May 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below